[ Price : $8.95]
Janssen Biotech and Janssen-Cilag file a BLA seeking approval for Stelara (ustekinumab) for treating adult patients with moderate ...[ Price : $8.95]
FDA approves a Baxalta NDA for Adynovate (antihemophilic factor [recombinant], pegylated), an extended circulating half-life recom...[ Price : $8.95]
Federal Register Notice: FDAs Vaccines and Related Biological Products Advisory Committee will meet 1/14/16 to hear updates on the...[ Price : $8.95]
FDA officials say clinical trial endpoints for investigational gene therapy products intended for treating cancer must be carefull...[ Price : $8.95]
Glades Drugs recalls compounded multivitamin capsules containing high amounts of Vitamin D3 (cholecalciferol) after receiving seve...[ Price : $8.95]
FDA approves a Bristol-Myers Squibb NDA for Empliciti (elotuzumab) for use in combination with two other therapies to treat multip...[ Price : $8.95]
FDA denies an Almatica Pharma petition asking the agency to impose specific bioequivalence requirements on any ANDAs that referenc...[ Price : $8.95]
Beiersdorf says FDA should deny a petition asking for enforcement action against the company for marketing a Nivea lotion as a cos...